Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732907 | SCV000860905 | uncertain significance | not provided | 2018-04-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086434 | SCV001006303 | likely benign | Walker-Warburg congenital muscular dystrophy | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002360859 | SCV002662142 | likely benign | Cardiovascular phenotype | 2020-04-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001830628 | SCV002091343 | likely benign | Autosomal recessive limb-girdle muscular dystrophy type 2I | 2021-08-12 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004535860 | SCV004709291 | likely benign | FKRP-related disorder | 2021-03-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |